ME02294B - Kristalni (s)-izopropil 2-(((s)-(((2r,3r,4r,5r)-5-(2 ,4-dioks0-3,4-dihidropirimidin-1-(2h)-il )-4 - fluor0-3-hidroksi-4-metiltetrahidrofuran-2- il)metoksi)(fenoksi)fosforil)amino)propanoat - Google Patents

Kristalni (s)-izopropil 2-(((s)-(((2r,3r,4r,5r)-5-(2 ,4-dioks0-3,4-dihidropirimidin-1-(2h)-il )-4 - fluor0-3-hidroksi-4-metiltetrahidrofuran-2- il)metoksi)(fenoksi)fosforil)amino)propanoat

Info

Publication number
ME02294B
ME02294B MEP-2015-199A MEP19915A ME02294B ME 02294 B ME02294 B ME 02294B ME P19915 A MEP19915 A ME P19915A ME 02294 B ME02294 B ME 02294B
Authority
ME
Montenegro
Prior art keywords
methyltetrahydrofuran
phosphoryl
dioxo
phenoxy
fluoro
Prior art date
Application number
MEP-2015-199A
Other languages
English (en)
French (fr)
Inventor
Bruce S Ross
Michael Joseph Sofia
Ganapati Reddy Pamulapati
Suguna Rachakonda
Hai-Ren Zhang
Byoung-Kwon Chun
Peiyuan Wang
Original Assignee
Gilead Pharmasset Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/783,680 external-priority patent/US8642756B2/en
Application filed by Gilead Pharmasset Llc filed Critical Gilead Pharmasset Llc
Priority claimed from PCT/US2011/030725 external-priority patent/WO2011123645A2/en
Publication of ME02294B publication Critical patent/ME02294B/me

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Claims (11)

1. Kristalni (S)-izopropil 2-(((S)-(((2R, 3R, 4R, 5R)-5-(2, 4-diokso-3, 4-dihidropirimidin-l(2H)-il)-4-fluoro-3-hidroksi-4-metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino)propanoat predstavljen formulom Sp-4: koji ima XRPD 20-refleksije (°) od oko: 6. 1, 8. 2, 10. 4, 12. 7, 17. 2, 17. 7, 18. 0, 18. 8, 19. 4, 19. 8, 20. 1, 20. 8, 21. 8, i 23. 3.
2. Kristalni (S)-izopropil 2-(((S)-(((2R, 3R, 4R, 5R)-5-(2, 4-diokso-3, 4-dihidropirimidin-l(2H)-il)-4-fluoro-3-hidroksi-4-metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino)propanoat prema patentnom zahtevu 1 koji ima XRPD 20-refleksije (°) od oko: 6. 08, 8. 2, 10. 38. 10. 85, 12. 17, 12. 7, 13. 73, 14. 1, 15. 91, 16. 83, 17. 17, 17. 66, 17. 95, 18. 79, 19. 1, 19. 41, 19. 8, 20. 11, 20. 82, 21. 81, 22. 03, 23. 03, 23. 26, 23. 64, 23. 89, i 24. 73 sa intenzitetima (%) od 66. 7, 62. 1, 29. 8, 10. 4, 12. 0, 66. 4, 14. 9, 13. 8, 3. 1, 8. 7, 19. 7, 56. 2, 37. 7, 59. 0, 14. 3, 37. 2, 46. 0, 68. 8, 100. 0, 36. 8, 7. 4, 14. 2, 21. 6, 6. 3, 7. 0, i 3. 3, redom.
3. Farmaceutska kompozicija koja sadrži kristalni (S)-izopropil 2-(((S)-(((2R, 3R, 4R, 5R)-5-(2, 4-diokso-3, 4-dihidropirimidin-l(2H)-il)-4-fluoro-3-hidroksi-4-metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino)propanoat patentnog zahteva 1 ili 2 i farmaceutski prihvatljiv medijum.
4. Farmaceutska kompozicija prema patentnom zahtevu 3, koja dalje sadrži drugo antivirusno sredstvo.
5. Farmaceutska kompozicija prema patentnom zahtevu 4, gde je drugo antivirusno sredstvo inhibitor HCV NS3 proteaze.
6. Farmaceutska kompozicija prema patentnom zahtevu 4, gde je drugo antivirusno sredstvo HCV NS5A inhibitor.
7. Kristalni (S)-izopropil 2-(((S)-(((2R, 3R, 4R, 5R)-5-(2, 4-diokso-3, 4-dihidropirimidin-l(2H)-il)-4-fluoro-3-hidroksi-4-metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino)propanoat patentnog zahteva 1 ili 2 za upotrebu kao lek.
8. Kristalni (S)-izopropil 2-(((S)-(((2R, 3R, 4R, 5R)-5-(2, 4-diokso-3, 4-dihidropirimidin-l(2H)-iI)-4-fluoro-3-hidroksi-4-metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino)propanoat patentnog zahteva 1 ili 2 za upotrebu u lečenju virusne infekcije izazvane hepatitisom C.
9. Upotreba kristalnog (S)-izopropil 2-(((S)-(((2R, 3R, 4R, 5R)-5-(2, 4-diokso-3, 4-dihidropirimidin-l(2H)-il)-4-fluoro-3-hidroksi-4-metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino)propanoata patentnog zahteva 1 ili 2 i drugog antivirusnog sredstva u izradi leka za lečenje virusne infekcije izazvane hepatitisom C.
10. Upotreba prema patentnom zahtevu 17, gde je drugo antivirusno sredstvo inhibitor HCV NS3 proteaze.
11. Upotreba prema patentnom zahtevu 17, gde je drugo antivirusno sredstvo HCV NS5A inhibitor.
MEP-2015-199A 2010-03-31 2011-03-31 Kristalni (s)-izopropil 2-(((s)-(((2r,3r,4r,5r)-5-(2 ,4-dioks0-3,4-dihidropirimidin-1-(2h)-il )-4 - fluor0-3-hidroksi-4-metiltetrahidrofuran-2- il)metoksi)(fenoksi)fosforil)amino)propanoat ME02294B (me)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US31954810P 2010-03-31 2010-03-31
US31951310P 2010-03-31 2010-03-31
US12/783,680 US8642756B2 (en) 2009-05-20 2010-05-20 Nucleoside phosphoramidates
PCT/US2011/030725 WO2011123645A2 (en) 2010-03-31 2011-03-31 Nucleoside phosphoramidates
EP11714465.9A EP2552930B1 (en) 2010-03-31 2011-03-31 Crystalline (s)-isopropyl 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihydropyrimidin-1-(2h)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate

Publications (1)

Publication Number Publication Date
ME02294B true ME02294B (me) 2016-02-20

Family

ID=55359000

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-2015-199A ME02294B (me) 2010-03-31 2011-03-31 Kristalni (s)-izopropil 2-(((s)-(((2r,3r,4r,5r)-5-(2 ,4-dioks0-3,4-dihidropirimidin-1-(2h)-il )-4 - fluor0-3-hidroksi-4-metiltetrahidrofuran-2- il)metoksi)(fenoksi)fosforil)amino)propanoat
MEP-2017-196A ME02846B (me) 2010-03-31 2011-03-31 Postupak za kristalizaciju (s) - izopropil 2- (((s) - (perfluorofenoksi)( fenoksi)fosforil)amino) propanoata

Family Applications After (1)

Application Number Title Priority Date Filing Date
MEP-2017-196A ME02846B (me) 2010-03-31 2011-03-31 Postupak za kristalizaciju (s) - izopropil 2- (((s) - (perfluorofenoksi)( fenoksi)fosforil)amino) propanoata

Country Status (4)

Country Link
BR (1) BR122013004621A2 (me)
ME (2) ME02294B (me)
RS (1) RS56229B1 (me)
SI (1) SI2552930T1 (me)

Also Published As

Publication number Publication date
ME02846B (me) 2018-01-20
SI2552930T1 (sl) 2016-02-29
RS56229B1 (sr) 2017-11-30
BR122013004621A2 (pt) 2016-11-22

Similar Documents

Publication Publication Date Title
HRP20151075T1 (hr) Kristalni (s)-izopropil 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-diokso-3,4-dihidropirimidin-1-(2h)-il)-4-fluoro-3-hidroksi-4-metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino) propanoat
HRP20211224T1 (hr) Derivati pirimidina za liječenje virusnih infekcija
HRP20150725T1 (hr) Kondenzirani imidazolilimidazoli kao antivirusni spojevi
IL207468A (en) HCV inhibitors and their use in the preparation of medicines for the treatment of HCV infections
HRP20151000T1 (hr) Antivirusni spojevi
ATE547103T1 (de) Hemmer des hepatitis-c-virus
EA022127B1 (ru) Ингибиторы вируса гепатита с
MX2010006210A (es) Inhibidores de serina proteasa de hcv de tripeptido fluorado.
JP2014504643A5 (me)
JP2013521279A5 (me)
WO2008002924A3 (en) Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors
JP2013514359A5 (me)
JP2013532725A5 (me)
MD20150036A2 (ro) Analogi de 2'-cloro nucleozide pentru tratarea hepatitei virale C
MX2010008699A (es) Derivados heterociclicos como inhibidores de virus de la hepatitis c.
JP2012504632A5 (me)
EP2542545A4 (en) INHIBITORS OF HEPATITIS C-VIRUS NS5B POLYMERASE
MX2010006209A (es) Derivados de quinoxalinilo.
MY169568A (en) Compounds and pharmaceutical compositions for the treatment of viral infections
CU23787B7 (es) Compuestos macrocíclicos como inhibidores de la replicación viral
EA201491180A1 (ru) 4'-азидо,3'-фторзамещенные производные нуклеозидов в качестве ингибиторов репликации рнк вируса гепатита с
MX2010008109A (es) Tripéptidos difluorizados como inhibidores de proteasa de serina de virus de hepatitis c (hcv).
MX2010008108A (es) Inhibidores de proteasa de serina de tripéptido de virus de hepatitis c (hcv) que contienen heteroarilo.
NZ600505A (en) Hepatitis c virus inhibitors
MX2012002958A (es) Compuestos antivirales heterociclicos.